Stroke education by emphasizing self-confidence to reduce risk factors and improve clinical outcomes for mild to moderate stroke patients

ISRCTN ISRCTN11495822
DOI https://doi.org/10.1186/ISRCTN11495822
ClinicalTrials.gov (NCT) Nil known
Clinical Trials Information System (CTIS) Nil known
Protocol serial number KET-4/UN2.F1/ETIK/PPM.00.02/2022
Sponsor University of Indonesia
Funders Direktorat Riset and Pengembangan, Universitas Indonesia, Kementerian Riset dan Teknologi /Badan Riset dan Inovasi Nasional
Submission date
04/01/2023
Registration date
05/01/2023
Last edited
31/05/2023
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Circulatory System
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Background and study aims
Education of stroke patients is the key to decreasing the worldwide burden of stroke. Stroke patients seldom transform their "knowledge" into "activity" due to a disconnect between "knowing" and "doing." This gap is caused by stroke patients' poor self-efficacy and lack of self-care. This study aims to assess the potential for reducing stroke risk in patients with mild to moderate ischemic stroke through self-care and self-confidence-based education.

Who can participate?
Patients aged over 18 years at stroke onset who meet the mild-to-moderate stroke criteria

What does the study involve? (for participants)
All participants will be included in integrative discharge planning for ischemic stroke patients, which includes integrated education and discharge preparation. Patients and families will also be provided with ways to care for themselves and increase their confidence level for self-care. The study will be conducted from the time the patient goes home until 3 months after discharge

What are the possible benefits and risks of participating?
The advantage that will be obtained is increasing insight and self-confidence to care for yourself or a family affected by ischemic stroke. Patients will also receive an educational booklet that can be used as educational material for themselves and their families. There is no fatal risk that can arise when participating in this study.

Where is the study run from?
Cipto Mangunkusumo National Hospital (Indonesia)

When is the study starting and how long is it expected to run for?
October 2021 to December 2023

Who is funding the study?
1. Directorate of Research & Development, University of Indonesia (Indonesia)
2. National Research and Innovation Agency (Indonesia)

Who is the main contact?
Dr Al Rasyid, al-rasyid@ui.ac.id

Contact information

Dr Al Rasyid
Principal investigator

Cinere
Depok
16512
Indonesia

ORCiD logoORCID ID 0000-0002-7568-8124
Phone +62 (0)812 1867 6230
Email al-rasyid@ui.ac.id
Mr Elvan Wiyarta
Scientific

Tanjung Duren
Jakarta
11643
Indonesia

ORCiD logoORCID ID 0000-0002-5676-7804
Phone +62 (0)813 8222 2670
Email elvan.wiyarta@ui.ac.id

Study information

Primary study designInterventional
Study designSingle-center interventional double-blinded randomized controlled trial
Secondary study designRandomised controlled trial
Study type Participant information sheet
Scientific titleExploring the self-efficacy and self-care based stroke care model for risk factor modification in mild to moderate stroke patients: a randomized controlled trial
Study acronymSelf-Care and self-efficacy On Risk Education for Stroke (SCORES)
Study objectivesSelf-efficacy-self-care-based stroke education can reduce the risk of stroke in patients with mild to moderate stroke compared to standard education only
Ethics approval(s)Approved January 2022, Faculty of Medicine Ethics Committee Universitas Indonesia (The Faculty of Medicine Ethics Committee, University of Indonesia - Cipto Mangunkusumo Hospital, Gedung Fakultas Kedokteran UI JI. Salemba Raya No.6, Jakarta 10430, PO Box 1358, Indonesia; +62 (0)213912477; humas@fk.ui.ac.id), ref: KET-4/UN2.F1/ETIK/PPM.00.02/2022
Health condition(s) or problem(s) studiedReduction of stroke risk factors through patient education based on self-care and self-efficacy
InterventionThe researchers enrol mild to moderate ischemic stroke patients during hospitalization in either the emergency department or the stroke unit at Cipto Mangunkusumo National Hospital. After informed consent is obtained, patients who fit the inclusion and exclusion criteria will be randomized to enhanced standard care or intervention following simple randomization procedures. A computer-generated list of random numbers is used to allocate the participants and was created by a statistician with no clinical involvement in the trial. The allocation sequence is concealed from the enrolling participants in sequentially numbered and sealed envelopes and placed in the researcher's ward at an approved location. The researcher in charge of carrying out the allocation then records each patient allocation. No sign is given to the patient or the patient's environment that could identify the patient's allocation group. Standard care for the participant in the ward is also carried out by nurses who are different from nurses who provide education to avoid bias. The nurse who provides education never meets the patient before the discharge education plan.

All trial arms, regardless of randomization group, will receive a standard of care, a self-care assessment, a self-efficacy assessment, and a stroke risk assessment, including blood pressure measurements, anthropometric measures, and risk factor assessments. Information about patients: demographics, self-care level, self-efficacy level, stroke risk score, NIH Stroke Scale/Score (NIHSS), mRS, Barthel index, blood viscosity, hospital length of stay, and comorbidity will be obtained at baseline.

In addition to standard education, participants in the intervention group will receive stroke education based on self-care and self-efficacy. Self-care and self-efficacy education follows the Hypertension Self-Care Instrument, validated in the study population and carried out for patients and their caregivers before the patient is discharged. Education is given in Indonesian by a team of doctors and nurses who have received special training on related interventions. Participants in the intervention group will also receive an Indonesian language booklet about increasing self-care and self-efficacy in stroke care. Intervention patients will be given education before discharge and will be followed up 1 month and 3 months after discharge.

After being discharged, all patients will be followed up through in-person interviews. All participants will receive a card with the time, location, and contact information for a follow-up appointment at Stroke Subspecialty Cipto Mangunkusumo National Hospital, to occur within 1 month and 3 months of discharge. Data will be collected regarding assessments of self-care, self-efficacy, stroke risk, measurements of anthropometric indices, and neurological examination. All data will be collected in Indonesian through interviews with participants by doctors and nurses, using standardized data collection instruments and reviewing medical records. In order to control for the Hawthorne Effect, the study team will call all participants at 2 weeks post-discharge, including those randomized to usual enhanced care, to see how they are feeling and capture any outcome events.
Intervention typeOther
Primary outcome measure(s)

1. Self-care and self-efficacy level is measured using the Hypertension Self-Care Instrument at baseline, 1 month, and 3 months after discharge
2. Stroke risk is measured using the Feigin Stroke Risk Score at baseline, 1 month, and 3 months after discharge

Key secondary outcome measure(s)

1. Blood viscosity measured using a micropapillary device at baseline, 1 month, and 3 months after discharge
2. Functional outcome measured using the modified Rankin Scale (mRS) score and Barthel index at baseline, 1 month, and 3 months after discharge
3. Element of risk factor for stroke measured using the Feigin Stroke Risk Score at baseline, 1 month, and 3 months after discharge

Completion date30/12/2023

Eligibility

Participant type(s)Patient
Age groupMixed
Lower age limit18 Years
SexAll
Target sample size at registration120
Total final enrolment120
Key inclusion criteria1. Diagnosed with mild to moderate ischemic stroke based on a clinical definition of focal neurologic deficits consistent with the vascular territory of the brain
2. Aged over 18 years at onset of event
3. Lived around Jakarta during the research process
4. Discharge to home
5. Speaking Indonesian
Key exclusion criteria1. Patients unable to give informed consent
2. Discharged to a long-term nursing home
3. Pre-stroke dementia history
4. Patients with end-stage cancer or other medical conditions resulting in mortality of less than 1 year
Date of first enrolment10/01/2022
Date of final enrolment10/01/2023

Locations

Countries of recruitment

  • Indonesia

Study participating centre

Cipto Mangunkusumo National Hospital
Pangeran Diponegoro No. 71
Jakarta
10430
Indonesia

Results and Publications

Individual participant data (IPD) Intention to shareYes
IPD sharing plan summaryPublished as a supplement to the results publication
IPD sharing planThe datasets generated and/or analysed during the current study will be published as a supplement to the results publication

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article results 11/05/2023 31/05/2023 Yes No
Participant information sheet Participant information sheet 11/11/2025 11/11/2025 No Yes
Protocol file 13/01/2023 No No
Statistical Analysis Plan 13/01/2023 No No

Additional files

ISRCTN11495822_PROTOCOL.pdf
Protocol file
ISRCTN11495822_PROTOCOL.pdf
Statistical Analysis Plan

Editorial Notes

31/05/2023: Publication reference added.
13/01/2023: Protocol and statistical analysis plan uploaded (not peer reviewed).
12/01/2023: Total final enrolment and acronym added.
04/01/2023: Trial's existence confirmed by the Faculty of Medicine Ethics Committee Universitas Indonesia.